Crane Co. Reports Second Quarter Results

10.08.2015 -

Crane Co. reported second quarter 2015 earnings of $0.95 per diluted share, compared to $1.00 per share in the second quarter of 2014. Excluding Special Items in both years, second quarter 2015 earnings per diluted share were $1.06, compared to $1.15 in the second quarter of 2014.

Crane Reports Fourth Quarter Results and Provides 2015 EPS Guidance

03.02.2015 -

Crane reported fourth quarter 2014 earnings of $0.95 per diluted share, compared to $0.84 per share in the fourth quarter of 2013. Fourth quarter 2014 results included Special Items, net, of $11.0 million in after tax charges, or $0.18 per diluted share. Fourth quarter 2013 results included Special Items, net, of $11.9 million in after tax charges, or $0.20 per diluted share.

Crane Launches New Products

27.11.2014 -

Crane ChemPharma & Energy are pleased to announce the launch of three new products during the 2014 Valve World Düsseldorf Conference & Expo (Hall 3, booth E51). The Xomox XLC, Xomox FK and Pacific CSV will be on display for the first time, in addition to the numerous products that comprise Crane’s comprehensive valve portfolio.

Crane Co. Reports Third Quarter Results

03.11.2014 -

Crane Co. reported third quarter 2014 earnings of $0.47 per diluted share, compared to $0.97 per share in the third quarter of 2013. Third quarter 2014 results included Special Items of $38.7 million in after-tax charges, or $0.65 per share. Third quarter 2013 results included Special Items of $4.1 million in after-tax charges, or $0.07 per share.

Crane ChemPharma & Energy Expands Pacific Valves Wedgeplug Line

27.10.2014 -

Characterized by simplicity of design, low energy usage and the innovative Wedgetorque operator, Pacific Wedgeplug valves from Crane are specifically engineered to address the challenges in severe service applications. Now available in ½” to 36” sizes, the range has been expanded to increase the breadth of solutions for customers in the refining, petrochemical and power generation industries.